<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Parasit Vectors</journal-id><journal-id journal-id-type="iso-abbrev">Parasit Vectors</journal-id><journal-title-group><journal-title>Parasites &#x00026; Vectors</journal-title></journal-title-group><issn pub-type="epub">1756-3305</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6521364</article-id><article-id pub-id-type="publisher-id">3495</article-id><article-id pub-id-type="doi">10.1186/s13071-019-3495-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Metamorphoses of Lyme disease spirochetes: phenomenon of <italic>Borrelia</italic> persisters</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Rudenko</surname><given-names>Natalie</given-names></name><address><email>natasha@paru.cas.cz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Golovchenko</surname><given-names>Maryna</given-names></name><address><email>marina@paru.cas.cz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kybicova</surname><given-names>Katerina</given-names></name><address><email>katerina.kybicova@szu.cz</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Vancova</surname><given-names>Marie</given-names></name><address><email>vancova@paru.cas.cz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.448361.c</institution-id><institution>Biology Centre CAS, Institute of Parasitology, </institution></institution-wrap>Branisovska 31, 37005 Ceske Budejovice, Czech Republic </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2184 1595</institution-id><institution-id institution-id-type="GRID">grid.425485.a</institution-id><institution>National Institute of Public Health, </institution></institution-wrap>Srobarova 48, 100 42 Prague 10, Czech Republic </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>12</volume><elocation-id>237</elocation-id><history><date date-type="received"><day>14</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>9</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The survival of spirochetes from the <italic>Borrelia burgdorferi</italic> (<italic>sensu lato</italic>) complex in a hostile environment is achieved by the regulation of differential gene expression in response to changes in temperature, salts, nutrient content, acidity fluctuation, multiple host or vector dependent factors, and leads to the formation of dormant subpopulations of cells. From the other side, alterations in the level of gene expression in response to antibiotic pressure leads to the establishment of a persisters subpopulation. Both subpopulations represent the cells in different physiological states. &#x0201c;Dormancy&#x0201d; and &#x0201c;persistence&#x0201d; do share some similarities, e.g. both represent cells with low metabolic activity that can exist for extended periods without replication, both constitute populations with different gene expression profiles and both differ significantly from replicating forms of spirochetes. Persisters are elusive, present in low numbers, morphologically heterogeneous, multi-drug-tolerant cells that can change with the environment. The definition of &#x0201c;persisters&#x0201d; substituted the originally-used term &#x0201c;survivors&#x0201d;, referring to the small bacterial population of <italic>Staphylococcus</italic> that survived killing by penicillin. The phenomenon of persisters is present in almost all bacterial species; however, the reasons why <italic>Borrelia</italic> persisters form are poorly understood. Persisters can adopt varying sizes and shapes, changing from well-known forms to altered morphologies. They are capable of forming round bodies, L-form bacteria, microcolonies or biofilms-like aggregates, which remarkably change the response of <italic>Borrelia</italic> to hostile environments. Persisters remain viable despite aggressive antibiotic challenge and are able to reversibly convert into motile forms in a favorable growth environment. Persisters are present in significant numbers in biofilms, which has led to the explanation of biofilm tolerance to antibiotics. Considering that biofilms are associated with numerous chronic diseases through their resilient presence in the human body, it is not surprising that interest in persisting cells has consequently accelerated. Certain diseases caused by pathogenic bacteria (e.g. tuberculosis, syphilis or leprosy) are commonly chronic in nature and often recur despite antibiotic treatment. Three decades of basic and clinical research have not yet provided a definite answer to the question: is there a connection between persisting spirochetes and recurrence of Lyme disease in patients?</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Borrelia burgdorferi</italic></kwd><kwd>Persisters</kwd><kwd>Dormant forms</kwd><kwd>Round bodies</kwd><kwd>Biofilm</kwd><kwd>Lyme disease</kwd><kwd>Persistent infection</kwd><kwd>Antibiotic treatment</kwd></kwd-group><funding-group><award-group><funding-source><institution>Ministry of Education, Youth and Sport of the Czech Republic</institution></funding-source><award-id>CZ.02.1.01/0.0/0.0/16_013/0001775</award-id><award-id>LM2015062 Czech-BioImaging</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Ministry of Health of the Czech Republic</institution></funding-source><award-id>NV19-05-00191</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par6">Lyme disease (LD) is a multisystem disorder caused by certain species of spirochetes from the <italic>Borrelia burgdorferi</italic> (<italic>sensu lato</italic>) complex. Since all <italic>Borrelia</italic> species are host-propagated bacteria that move between a vertebrate host and tick vector, the spirochetes have developed strategies to sense and survive in these diverse environments [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Survival is achieved by altering the level of gene expression in response to changes in temperature, pH, salts, nutrient content, multiple host and vector dependent factors [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]. Nutrients, especially carbon sources, and/or their metabolic by-products seem to provide regulatory and chemotactic signals that guide the spirochete as it moves between hosts and vectors. The spirochetes that are exposed to antibiotic treatment are able to survive by regulation of the differential expression of genes involved in spirochete pathogenicity and the mechanism of persister formation [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. However, the change in gene expression level is not the only route to spirochete survival. Signals that <italic>Borrelia</italic> receives from hostile environments evoke morphological alterations that keep the pathogen alive and induce the production of atypical forms or persisters that are refractory to elimination. The formation of persisters <italic>in vitro</italic> and <italic>in vivo</italic> is a reversible process that establishes the basis for disease recurrence when the hostile pressure drops [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par7">The successful persistence of spirochetes within the host depends on evading the host&#x02019;s immune system, e.g. hiding of spirochetes within the extracellular matrix rather than using the host tissues for reproduction or growth [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>]. Multiple experimental animal studies have shown that <italic>Borrelia</italic> frequently establishes persistent infection in diverse vertebrate hosts including laboratory mice of C3H/HeJ, BALB/cByJ, C3H/HeNCrlBR, C3H-<italic>scid</italic>, SJL or B6 Myd88&#x02212;/&#x02212; genotypes [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>], white-footed mice <italic>Peromyscus leucopus</italic> [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], rats [<xref ref-type="bibr" rid="CR31">31</xref>], hamsters [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], guinea pigs [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], gerbils [<xref ref-type="bibr" rid="CR36">36</xref>], dogs [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref>], horses [<xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>] and non-human primates [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>]. Clinical evidence extends this paradigm to humans including those who underwent antibiotics treatment [<xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par8">The hosts&#x02019; immune responses to LD spirochete, pharmacokinetic and pharmacodynamic parameters of antibiotic treatment in animals and humans, infectious dose and the route of infection are not the same [<xref ref-type="bibr" rid="CR86">86</xref>]. It is clear that results obtained on laboratory animal models might not be simply applied to explain the phenomenon of persisters in human LD. However, the extended examples of diverse strategies used by LD spirochete in its competition for survival, i.e. active immune suppression, induction of immune tolerance, phase and antigenic variation, intracellular seclusion, or incursion into immune privileged sites, provide strong evidence of the capability of spirochetes to persist in vertebrate hosts [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR87">87</xref>].</p></sec><sec id="Sec2"><title>Facing antibiotic challenge</title><p id="Par9">Frequent failures to respond to antibiotic treatment have recently become a serious public health problem. The common explanation of such cases is the emergence of a superinfection as a result of the development of bacterial resistance. Bacteria are able to develop resistance to the majority of clinically used antibiotics and the extended emergence of multi-drug-resistant pathogens is secured by the wide use of antibiotics in daily life by the general population, in hospitals, in agriculture or farming. There is no doubt that resistance is the main culprit of antibiotic treatment failures; however, less obvious reasons must be taken into consideration as well. One of these reasons is a phenomenon known as bacterial persistence, the case when bacteria survive the killing action of antibiotics by changing its physiological state.</p><p id="Par10">Lyme disease is an infectious disease that can usually be successfully cured by antibiotic therapy at the very early stages of infection, targeting the replicative form of the spirochete [<xref ref-type="bibr" rid="CR88">88</xref>&#x02013;<xref ref-type="bibr" rid="CR90">90</xref>]. Antibiotic treatment of microbial populations in general and <italic>B. burgdorferi</italic> (<italic>s.l.</italic>) in particular, results in biphasic killing [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], eliminating the growing bacteria and inducing the appearance of a subpopulation of multi-drug tolerant cells, persisters [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. When the antibiotic concentration exceeds a certain threshold, only persister cells survive [<xref ref-type="bibr" rid="CR18">18</xref>]. Persisters are tolerant to antibiotics without having acquired resistance to them through genetic modification [<xref ref-type="bibr" rid="CR93">93</xref>]. Persistence is a non-inheritable feature. This discriminates persistent cells from resistant mutants, which exhibit stable, inheritable drug insensitivity [<xref ref-type="bibr" rid="CR94">94</xref>]. A decrease of antibiotic pressure leads to the rise of a cell population that is as susceptible to antibiotics as the original population. A raised cell population called &#x0201c;reverters&#x0201d; constitutes a very small proportion of persisters that could revert to replicating forms and cause relapse or chronic infection [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR95">95</xref>].</p><p id="Par11">Persistence, as the response to hostile challenge, is an essential strategy for the complex life-cycle of <italic>Borrelia</italic> in both vector ticks and reservoir hosts, and likely applies to regular vertebrate hosts as well as to incidental ones such as humans. The ability of LD spirochetes to transform into persisters in response to antibiotic treatment explains the surprising resistance of chronic infection to therapy with antibiotics that are effective in the elimination of replicative <italic>Borrelia in vitro</italic> [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec3"><title>Different stressors: diverse pleomorphic forms</title><p id="Par12">In addition to the well-known flat-wave forms of <italic>B. burgdorferi</italic> (<italic>s.l.</italic>) spirochetes, the existence of non-motile atypical morphologies such as looped or ring shaped forms, blebs, round bodies (RB) and cell wall deficient forms, spirochete colonies or biofilm aggregates have been described [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR95">95</xref>&#x02013;<xref ref-type="bibr" rid="CR105">105</xref>]. The generalized definition of &#x0201c;round bodies&#x0201d; also includes coccoid-, globular- or spherical bodies, granules, cysts, sphaeroplasts or vesicles; all of these are viable reproductive propagules whose formation is induced by hostile environmental conditions [<xref ref-type="bibr" rid="CR106">106</xref>]. The morphological changes of motile <italic>B. burgdorferi</italic> (<italic>s.l.</italic>) spirochetes are observed <italic>in vitro</italic> in response to incubation with water or serum starvation, a change of media composition, gas composition, oxidative stress, pH or temperature fluctuation, media acidity-alkalinity fluctuation, concentrations of salts, sugars or other organic compounds, or as a response to antibiotic treatment [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR104">104</xref>&#x02013;<xref ref-type="bibr" rid="CR108">108</xref>]. The formation of RBs in culture is induced by aging, and the appearance of RBs correlates with the disappearance of motile spirochetes [<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Mistakenly, transformation of the motile form into a RB was considered as a decrease of pathogen viability. However, even though RBs are less motile than spirochetes in a log phase culture, they are able to twitch or move laterally and revert to the active growing reproductive wave-form spirochetes under the favorable conditions [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR103">103</xref>&#x02013;<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. In addition to spirochetes from the <italic>B. burgdorferi</italic> (<italic>s.l.</italic>) complex, reversible pleomorphism has been confirmed in other species from the genus <italic>Spirochaeta</italic> [<xref ref-type="bibr" rid="CR110">110</xref>&#x02013;<xref ref-type="bibr" rid="CR113">113</xref>] and strengthened by the discovery of <italic>Spirochaeta coccoides</italic>, a new member of the genus <italic>Spirochaeta</italic> that grows and reproduces in RB forms only [<xref ref-type="bibr" rid="CR111">111</xref>]. The formation of RBs <italic>in vitro</italic> as a response to exposure to the &#x003b2;-lactam antibiotics commonly recommended for LD treatment was described more than 20 years ago [<xref ref-type="bibr" rid="CR105">105</xref>]. Persistence of <italic>Borrelia</italic> in hosts after antibiotic treatment has been already confirmed [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Atypical cystic forms were also observed in the cerebral cortex of a patient with chronic Lyme neuroborreliosis [<xref ref-type="bibr" rid="CR101">101</xref>]. <italic>Borrelia</italic> aggregates or biofilms have been detected in skin biopsies isolated from patients who developed rare but typical lymphocytomas after a tick bite [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. Biofilms, consisting of bacteria embedded in a self-produced polysaccharide matrix, are known to cause chronic infections due to their tolerance to antibiotic treatment and resistance to host serum complement [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR116">116</xref>].</p></sec><sec id="Sec4"><title>Different susceptibility of persisters to antibiotics</title><p id="Par13">Persisters are highly heterogeneous [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR96">96</xref>&#x02013;<xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Stress persisters differ from antibiotic persisters of the same <italic>Borrelia</italic> species due to the origin of condition that triggered their transformation. <italic>In vitro</italic> persisters differ from <italic>in vivo</italic> persisters due to the difference in environment in which the spirochetes reside [<xref ref-type="bibr" rid="CR95">95</xref>]. It is still unknown if the same morphological forms, for example RBs formed in response to antibiotic exposure, are the same as RBs that are present in excess in stationary growth culture [<xref ref-type="bibr" rid="CR109">109</xref>]. Recent studies confirmed that the susceptibility of heterogeneous persisters to a diverse spectrum of antibiotics is also different [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. Results of the study of three morphological forms of <italic>Borrelia in vitro</italic> revealed that five antimicrobial drugs commonly used as monotherapy in LD cases (doxycycline, amoxicillin, tigecycline, metronidazole and tinidazole) showed different potential in eradicating spirochetes, round bodies and biofilm-like colonies [<xref ref-type="bibr" rid="CR102">102</xref>]. While significant killing was shown by all five drugs in the case of replicating spirochetes (85&#x02013;90%) and round bodies (68&#x02013;90%), neither one of the studied drugs was able to reduce the spirochete colony formation more than 55%. In the same study, viable spirochetes were detected in 70&#x02013;85% of biofilm-like colonies [<xref ref-type="bibr" rid="CR102">102</xref>]. Another study [<xref ref-type="bibr" rid="CR117">117</xref>] revealed that tolerance to antibiotics is increased by different forms of spirochetes as culture ages, from log phase to stationary phase, from spirochete form to RB, micro-colonies or biofilms. The same study confirmed that the use of multiple drugs (triple combination) is much more effective in eradicating spirochete persisters. The complete eradication of biofilm-like spirochete micro-colonies <italic>in vitro</italic> was confirmed for a combination of daptomycin&#x000a0;+&#x000a0;doxycycline&#x000a0;+&#x000a0;cefoperazone, something that has not been achieved before with any single, dual or even triple drug combination [<xref ref-type="bibr" rid="CR117">117</xref>]. Another option for successful eradication of <italic>Borrelia</italic> persisters <italic>in vitro</italic> is the pulse dosing of antibiotics [<xref ref-type="bibr" rid="CR18">18</xref>]. While a combination of multiple antibiotics from different classes analyzed in the mentioned study did not improve the killing of persisters, four pulse doses of cetriaxone eradicated all live spirochetes in culture, including persisters [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p id="Par14">The antibiotic treatment of LD is a real challenge, sometimes with unpredicted outcomes, and is another paradox in the LD portfolio. Although seemingly illogical, multiple frontline antibiotics used to cure early LD are triggering, at much lower concentrations than used in therapy, the transformation of the spiral form of <italic>Borrelia</italic> into varieties of persisting forms [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. As a result, the <italic>Borrelia</italic> population becomes tolerant to the antibiotics that induced the morphological transformation. A good example of this paradox is doxycycline and amoxicillin, which at high concentrations are capable of eliminating 98% of replicating <italic>Borrelia</italic>, but show poor activity against a stationary phase culture that is rich in persisting forms. Both drugs are ineffective against RBs, the formation of which they induce in culture [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. It is interesting to note that morphologically changed forms represent spirochete populations with different gene expression profiles, characteristic for the specific antibiotic, doxycycline or amoxicillin, used for <italic>in vitro</italic> culture treatment. It was shown that treatment of <italic>B. burgdorferi</italic> B31 culture for six days with 50&#x000a0;&#x003bc;g/ml of doxycycline or 50&#x000a0;&#x003bc;g/ml of amoxicillin resulted in differential expression of 675 genes in the doxycycline-tolerant population (340 downregulated and 335 upregulated) and 516 genes in the amoxicillin-tolerant population (174 downregulated and 342 upregulated) [<xref ref-type="bibr" rid="CR12">12</xref>]. Binding to the 30S ribosomal subunit, doxycycline obstructs the protein synthesis that causes the cell envelope defect. Amoxicillin inhibits the synthesis of bacterial cell walls that results in the death of bacteria. A comparison of the pathways of doxycycline- and amoxicillin-induced RBs shows that they share some common features that likely contribute to the enabling of spirochete survival under antibiotic pressure by downregulation of outer membrane lipoprotein gene expression. It is possible that one of the strategies spirochetes use to survive antibiotic treatment is the reduction of drug targets [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par15">Amoxicillin-induced RBs have been used as an alternative model to stationary phase culture of <italic>B. burgdorferi</italic> in screening drugs active against persisters <italic>in vitro.</italic> Both models showed different susceptibilities to the same tested drugs. Because the structure of stationary phase culture is more complex, as it is enriched with RBs, micro-colonies and biofilm- like aggregates, its tolerance to tested antibiotics was shown to be higher in comparison to amoxicillin-induced round bodies [<xref ref-type="bibr" rid="CR109">109</xref>].</p></sec><sec id="Sec5"><title>Genetic factors involved in persistence</title><p id="Par16">A genetically homogeneous population of spirochetes can dynamically alter gene expression in response to changing environmental conditions. When external stimuli on a bacterial subpopulation randomly trigger expression of genes that induce a state of dormancy, then a persister subpopulation can emerge. Persistence only occurs in a subpopulation of <italic>Borrelia</italic> cells that faces hostile pressure and is characterized by switching between two phenotypes, i.e. susceptible and persistent. <italic>Borrelia burgdorferi</italic> has been shown to persist when treated with tetracycline antibiotics [<xref ref-type="bibr" rid="CR49">49</xref>]. Even though the mechanism of persistence for <italic>Borrelia</italic> has not yet been described, studies of bacterial persisters in fungi, parasites or viruses with a number of identified pathways and genes have shed light on the mechanism of persister formation and survival. The identified pathways in bacterial persisters could serve as potential targets for the development of new anti-persister drugs. These include, for example, toxin-antitoxin modules (<italic>hipBA</italic>, <italic>relBE</italic>, <italic>mazEF</italic>, <italic>tisAB</italic>, <italic>mqsR</italic>, <italic>hhA</italic>, <italic>hokA</italic>, <italic>cspD</italic>, <italic>pasT</italic>), stringent response (<italic>relA</italic>, <italic>dksA</italic>), DNA repair or protection (<italic>lexA</italic>, <italic>recA</italic>, <italic>recB</italic>, <italic>xerC</italic>, <italic>xerD</italic>, <italic>dps</italic>), phosphate metabolism (<italic>phoU</italic>), alternative energy production (<italic>sucB</italic>, <italic>ubiF</italic>, <italic>glpD</italic>, <italic>plsB</italic>, <italic>tgs1</italic>), anti-oxidative stress or macromolecule degradation (superoxide dismutase, catalase) or signaling pathways (<italic>comE/comC; tnaA</italic>, <italic>oxyR</italic>, <italic>flu</italic>, <italic>pspBC</italic>) (for review see [<xref ref-type="bibr" rid="CR95">95</xref>]). As <italic>in vitro</italic> persisters differ from <italic>in vivo</italic> persisters, a drug that can kill all <italic>in vitro</italic> persisters is not guaranteed to do so <italic>in vivo</italic>. Nevertheless, the <italic>in vitro</italic> persisters may share some common features with <italic>in vivo</italic> persisters and <italic>in vitro</italic> persister models should still have significant value in persister studies as surrogates of <italic>in vivo</italic> persisters. Possible overlap between different persisters can be studied using single-cell techniques or RNA sequencing analysis to determine the expression pattern of genes that are differentially regulated by the pathogen as a survival strategy in response to hostile pressure.</p></sec><sec id="Sec6"><title>Biofilms</title><p id="Par17">In general, biofilm formation is an example of bacterial adaptation to a changing environment, occurring primarily for four reasons: (i) defense; (ii) colonization; (iii) community; and (iv) the default mode of bacterial growth [<xref ref-type="bibr" rid="CR118">118</xref>]. In particular, biofilm formation is a stage of microbial development and a part of the mechanism of establishment of chronic bacterial infection [<xref ref-type="bibr" rid="CR119">119</xref>&#x02013;<xref ref-type="bibr" rid="CR121">121</xref>]. More than 40 years have already passed from the first mention of tangled fibers of polysaccharides that extend from the cell surface and form &#x0201c;glycocalyx&#x0201d; around the individual cells or a colony of bacteria. The glycocalyx-mediated adhesion was described as a major determinant in the initiation and progression of the wide spectrum of bacterial diseases, from dental caries to pneumonia [<xref ref-type="bibr" rid="CR122">122</xref>]. The new description defines biofilms as a microbial-derived sessile community of cells irreversibly attached to a substratum, interface or to each other, embedded in a matrix of extracellular polymeric substances (EPS) secreted by them and exhibit an altered phenotype of growth and gene transcription [<xref ref-type="bibr" rid="CR119">119</xref>]. Biofilms are complex structures, highly resistant to environmental and therapeutic pressure. The primary polymeric compound of extracellular polymeric substance is alginate, a non-sulfated mucopolysaccharide described as a major biofilm component for multiple bacterial species, including those from the order Spirochaetales, <italic>Leptospira biflexa</italic> and <italic>Treponema denticola</italic> [<xref ref-type="bibr" rid="CR123">123</xref>, <xref ref-type="bibr" rid="CR124">124</xref>] and <italic>Borrelia burgdorferi</italic> [<xref ref-type="bibr" rid="CR96">96</xref>]. Even though the chemical structure of mature biofilms is diverse and includes phospholipids, polysaccharides, proteins, glycoproteins, embedded calcium and extracellular DNA (eDNA), alginine, calcium and eDNA are considered as a typical markers of biofilms [<xref ref-type="bibr" rid="CR96">96</xref>]. The compilation of genes, conducted by K. Jefferson, that are required for biofilm formation (the cause genes) and those differentially expressed in an established biofilms (the effect genes) in multiple bacterial species include numerous genes involved in adhesion, quorum sensing, cell wall synthesis, metabolism, stress response division and motility [<xref ref-type="bibr" rid="CR118">118</xref>]. Biofilms might be formed by a single bacteria species or represent a multi-species community attached to biotic or abiotic surfaces [<xref ref-type="bibr" rid="CR121">121</xref>]. The physical characteristic of surfaces influence bacterial attachment only to a minor extent, showing that smooth surfaces are colonized with the same success as rough ones [<xref ref-type="bibr" rid="CR125">125</xref>]. Once attached to the surface bacteria go through a series of changes that are required for adaptation to the life on surface. Extensive production of EPS is a common adaptation step; it protects the biofilms and might result in biocide resistance [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. The changes of environmental conditions triggers the transition of free-living bacteria to life on a surface that starts with the early stages that includes cell-surface and cell-cell interactions, followed by the development of mature biofilms and the return to a planktonic mode of growth. Those environmental signals vary and might differ among bacterial species, but in general what might influence the biofilms formation is the media composition/nutrition, temperature, pH, osmolarity, iron or oxygen [<xref ref-type="bibr" rid="CR121">121</xref>]. Surface-attached bacteria are often associated with an increased synthesis of EPS and the development of antibiotic resistance, the feature that makes mature biofilms a serious clinical problem. It is known that EPS prevents the access of antibiotics to bacterial cells in the biofilm using different mechanisms that include physical or chemical diffusion barriers to antibiotic penetration, slow growth of the biofilms, activation of the stress response or appearance of a biofilm-specific phenotype [<xref ref-type="bibr" rid="CR128">128</xref>].</p><p id="Par18">The mode of biofilm formation of the causative agent of Lyme disease highly resembles that of other bacteria [<xref ref-type="bibr" rid="CR129">129</xref>]. It has been shown that <italic>Borrelia</italic> is able to form colonies and develop aggregates with characteristic features of biofilms on biotic and abiotic substrates in a static or low-share-force environment. The use of the atomic force microscopy revealed the presence of channel-like structures in <italic>Borrelia</italic> biofilms that have been previously described in other biofilms and presumably serve as the routes of distribution of the oxygen and nutrition [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Sapi et al. [<xref ref-type="bibr" rid="CR96">96</xref>] showed that the protective extracellular substrate of <italic>Borrelia</italic> aggregates is predominantly composed of alginate with calcium and extracellular DNA. However, contrary to the other bacterial species that share the same pathway for alginine production, regulated by clustered <italic>algA</italic>, <italic>algD</italic> and <italic>algE</italic> genes [<xref ref-type="bibr" rid="CR131">131</xref>], <italic>Borrelia</italic> most probably uses a yet unknown pathway of alginate production as its genome lacks the genes homologous to that mentioned above. An analysis of the key components of <italic>Borrelia</italic> biofilm formation highlighted the impact of RpoN-RpoS alternative sigma factor pathways that are involved in the bacterial response to the environmental stresses and are responsible for sensing environmental stimuli [<xref ref-type="bibr" rid="CR132">132</xref>]. The RpoN-RpoS signal-transduction pathway secures the successful transmission of the spirochete from tick to host, regulating the expression of over 100 genes involved in the infectious cycle, survival and stress response of <italic>Borrelia</italic> [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]. Another regulatory pathway vital for <italic>Borrelia</italic> biofilm formation is the quorum sensing system, that by autoinducers triggers the population-wide differential regulation of genes involved in biofilm formation [<xref ref-type="bibr" rid="CR135">135</xref>&#x02013;<xref ref-type="bibr" rid="CR137">137</xref>].</p><p id="Par19"><italic>Borrelia</italic> biofilms have already been described in the midgut of infected tick nymphs during blood-feeding [<xref ref-type="bibr" rid="CR5">5</xref>]. Using confocal and epifluorescence microscopy, the authors confirmed that during the blood-feeding <italic>Borrelia</italic> spirochetes progress through the nymphal midgut as epithelial cell-associated networks of non-motile organisms. <italic>Borrelia</italic> biofilms have also been detected in human infected skin [<xref ref-type="bibr" rid="CR114">114</xref>]. The reoccurrence of the disease, the ability of spirochetes to evade the host immune system and the ability to resist antibiotic treatment strongly supports the existence of biofilm-like protective structures in infected patients.</p></sec><sec id="Sec7" sec-type="conclusion"><title>Conclusions</title><p id="Par20">The list of antibiotics recommended for LD treatment at the early stages of infection is expanding [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Current antibiotics are efficient in killing the growing replicative form of spirochetes, but they have rather insufficient activity against non-growing persistent forms. It has been confirmed that monotherapy of <italic>Borrelia</italic> infection with &#x003b2;-lactam, tetracycline, fluoroquinolone, sulfonamide, macrolide, lipopeptide, glycopeptides, aminoglycoside or antitumor antibiotics are not adequate. Such treatment fails to eliminate spirochetes in <italic>in vitro</italic> culture and leaves viable and effective persisters in treated vertebrates, including humans [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. The obvious need in antibiotics with strong anti-persister activity has led to the identification of drugs that act differently from current LD antibiotics [<xref ref-type="bibr" rid="CR117">117</xref>]. However, even anti-persister drugs such as daptomycin, clofazimine or daunomycin cannot kill different persister forms such as cysts, round bodies, micro-colonies or biofilms alone. A combination of two or three drugs from different classes of antibiotics with different mechanisms of action along with the use of sulfa drugs shows significant improvement in eliminating multiple persisters&#x02019; forms <italic>in vitro</italic>. Pulse dosing treatment shows great potential for eradicating persisters and seems to be a promising scheme for LD treatment. The interest in identifying alternative drug candidates with a high activity against multiple persister forms is growing. The other known &#x0201c;agent&#x0201d;, comparable by its strength to triple-combination antibiotics treatment and efficient in eliminating log phase spirochetes as well as reducing persisters (by 94%), is <italic>Stevia rebaudiana</italic>, the plant widely known as honey leaf or sweet leaf [<xref ref-type="bibr" rid="CR138">138</xref>]. Most probably the killing power of this &#x0201c;agent&#x0201d;, which is the whole leaf extract of the plant, is the result of the synergy of multiple natural compounds not yet identified. Recently, the screening of wide set of essential oils revealed candidates with an even stronger anti-persister activity than was described for some anti-persister drugs. For example, oregano oil and its active component carvacrol, cinnamon bark or clove bud were more efficient against the stationary phase and biofilms of Lyme disease spirochete than 40 &#x000b5;M daptomycin. For comparison, 0.05% cinnamaldehyde, the active component of cinnamon bark essential oil, sterilized the LD spirochete at stationary phase and garlic essential oil was successful in killing of all forms of <italic>Borrelia</italic> at a concentration of 0.05%. These results were confirmed by the absence of bacterial regrowth after 21&#x000a0;days of subculture and correspond to results obtained by culture treatment with 5 &#x000b5;g/ml of triple-drugs daptomycin + doxycycline + cefuroxime [<xref ref-type="bibr" rid="CR139">139</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]. The majority of published results, dealing with promising or fairly successful anti-<italic>Borrelia</italic> drugs or their combinations, were obtained <italic>in vitro</italic>. There is no doubt that their effect on spirochetes <italic>in vivo</italic> will be different, may be unexpected, and definitely unpredictable. Evaluating the elimination capability of anti-<italic>Borrelia</italic> drugs or finding alternative candidates against multiple non-replicating forms of LD spirochetes should be taken to another level. Until the same experiments are conducted <italic>in vivo</italic>, involving multiple laboratory animal models, concerns about successful LD therapy protocol will remain at the discussion or speculation level. The success of LD therapy depends on how early antibiotic treatment is started. The question is how early is early enough to start antibiotic treatment in order to assure elimination of the replicating forms of spirochetes in an infected host, if a 7&#x02013;10&#x000a0;day-old <italic>in vitro</italic> culture already contains multiple persistent forms of the pathogen [<xref ref-type="bibr" rid="CR109">109</xref>]. If the signature marker of Lyme disease, erythema migrans, does not develop in a person after a tick bite, antibiotic treatment will not be initiated immediately. How much time might the motile form of bacteria need to change its morphology or to hide in vertebrate host tissues <italic>in vivo</italic> when such changes triggered by an unfriendly environment <italic>in vitro</italic> can occur in minutes or hours? Even if antibiotic monotherapy is started shortly after exposure to a tick, the LD treatment paradox could occur anyway: frontline LD antibiotics can trigger the establishment of a persister subpopulation <italic>in vivo</italic> as it has been proven by the confirmation of chronic infection in multiple animal species and humans [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Atypical dormant spirochete forms, persisters, survive in a <italic>Borrelia</italic>-infected host for years, regardless of antibiotic treatment. The recurrence of LD likely happens because persisters may convert back into motile replicating infective forms under favorable growth conditions. The treatment of LD requires knowledge of its history and <italic>Borrelia</italic> pleomorphism in its natural environment [<xref ref-type="bibr" rid="CR106">106</xref>]. The theory that chronic spirochete infections in humans are examples of symbioses that developed between the host and pathogen over time has been proposed for LD [<xref ref-type="bibr" rid="CR106">106</xref>]. The human-<italic>Borrelia</italic> interaction represents co-evolved spirochete-tick-host relationships highly integrated on genetic, metabolic and behavioral levels. From this point of view LD is a manifestation of long-lasting genetically integrated symbioses, and the disease symptoms are the expression of symbiogenesis to which many aspects of the host immune system respond [<xref ref-type="bibr" rid="CR106">106</xref>]. Symbiogenesis means cooperation between species in order to increase their survival. While the benefit of symbiosis to the spirochete is obvious, what is the benefit of this symbiosis to the host? The successful persistence of spirochetes within the host is known to depend on their ability to use the host regulatory proteins to avoid recognition and eradication by its complement. Inability to understand chronic LD as ancient co-evolved host-pathogen symbioses might lead to misdiagnoses and insufficient therapies. The probability that chronic LD arises from a persisting infection is real. Regardless of the cause of chronic LD, i.e. persisting forms hidden in biofilms [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR96">96</xref>], cell-wall deficient forms [<xref ref-type="bibr" rid="CR31">31</xref>], or round bodies [<xref ref-type="bibr" rid="CR15">15</xref>], the <italic>in vivo</italic> treatment options for all of them are very limited. Addressing this problem requires a new comprehensive examination of the complex and controversial subject called chronic Lyme disease.
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>LD</term><def><p id="Par2">Lyme diseases</p></def></def-item><def-item><term>RB</term><def><p id="Par3">round bodies</p></def></def-item><def-item><term>EPS</term><def><p id="Par4">extracellular polymeric substances</p></def></def-item><def-item><term>eDNA</term><def><p id="Par5">extracellular DNA</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Natalie Rudenko and Maryna Golovchenko contributed equally to this work</p></fn></fn-group><ack><title>Acknowledgements</title><p>We are grateful to all research groups and the authors, cited in our paper, whose work encouraged this discussion. We are grateful to Marcia E. Herman-Giddens for her useful comments and help in manuscript language correction.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>NR and MG developed the concept of the paper and wrote a draft version of the review. NR, MG, KK and MV contributed to the writing, editing and the revision of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by the Ministry of Education, Youth and Sport (LM2015062 Czech-BioImaging and CZ.02.1.01/0.0/0.0/16_013/0001775) and Ministry of Health of the Czech Republic (NV19-05-00191).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><sec><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec><title>Consent for publication</title><p>Not applicable.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Girschick</surname><given-names>HJ</given-names></name></person-group><article-title>Molecular survival strategies of the Lyme disease spirochete <italic>Borrelia burgdorferi</italic></article-title><source>Lancet Infect Dis.</source><year>2004</year><volume>4</volume><fpage>575</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(04)01132-6</pub-id><pub-id pub-id-type="pmid">15336225</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovius</surname><given-names>J</given-names></name><name><surname>van Dam</surname><given-names>AP</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name></person-group><article-title>Tick&#x02013;host&#x02013;pathogen interactions in Lyme borreliosis</article-title><source>Trends Parasitol</source><year>2007</year><volume>23</volume><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2007.07.001</pub-id><pub-id pub-id-type="pmid">17656156</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fikrif</surname><given-names>E</given-names></name><name><surname>Narasimhan</surname><given-names>S</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic>-traveling incognito?</article-title><source>Microb Infect</source><year>2006</year><volume>8</volume><fpage>1390</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2005.12.022</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraiczy</surname><given-names>P</given-names></name></person-group><article-title>Hide and seek: how Lyme disease spirochetes overcome complement attack</article-title><source>Front Immunol</source><year>2016</year><volume>7</volume><fpage>385</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00385</pub-id><pub-id pub-id-type="pmid">27725820</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham-Ems</surname><given-names>SM</given-names></name><name><surname>Caimano</surname><given-names>MJ</given-names></name><name><surname>Pal</surname><given-names>U</given-names></name><name><surname>Wolgemuth</surname><given-names>CW</given-names></name><name><surname>Eggers</surname><given-names>CH</given-names></name><name><surname>Balic</surname><given-names>A</given-names></name><etal/></person-group><article-title>Live imaging reveals a biphasic mode of dissemination of <italic>Borrelia burgdorferi</italic> within ticks</article-title><source>J Clin Investig</source><year>2009</year><volume>119</volume><fpage>3652</fpage><lpage>3665</lpage><pub-id pub-id-type="doi">10.1172/JCI39401</pub-id><pub-id pub-id-type="pmid">19920352</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuels</surname><given-names>DS</given-names></name></person-group><article-title>Gene regulation in <italic>Borrelia burgdorferi</italic></article-title><source>Annu Rev Microbiol.</source><year>2011</year><volume>2011</volume><issue>65</issue><fpage>479</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.112408.134040</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drecktrah</surname><given-names>D</given-names></name><name><surname>Lybecker</surname><given-names>M</given-names></name><name><surname>Popitsch</surname><given-names>N</given-names></name><name><surname>Rescheneder</surname><given-names>P</given-names></name><name><surname>Hall</surname><given-names>LS</given-names></name><name><surname>Samuels</surname><given-names>DS</given-names></name></person-group><article-title>The <italic>Borrelia burgdorferi</italic> RelA/SpoT homolog and stringent response regulate survival in the tick vector and global gene expression during starvation</article-title><source>PLoS Pathog.</source><year>2015</year><volume>11</volume><fpage>e1005160</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005160</pub-id><pub-id pub-id-type="pmid">26371761</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brorson</surname><given-names>O</given-names></name><name><surname>Brorson</surname><given-names>SH</given-names></name></person-group><article-title>A rapid method for generating cystic forms of <italic>Borrelia burgdorferi</italic> and their reversal to mobile spirochetes</article-title><source>APMIS.</source><year>1998</year><volume>106</volume><fpage>1131</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1111/j.1699-0463.1998.tb00269.x</pub-id><pub-id pub-id-type="pmid">10052721</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akins</surname><given-names>DR</given-names></name><name><surname>Bourell</surname><given-names>KW</given-names></name><name><surname>Caimano</surname><given-names>MJ</given-names></name><name><surname>Norgard</surname><given-names>MV</given-names></name><name><surname>Radolf</surname><given-names>JD</given-names></name></person-group><article-title>A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state</article-title><source>J Clin Investig.</source><year>1998</year><volume>101</volume><fpage>2240</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.1172/JCI2325</pub-id><pub-id pub-id-type="pmid">9593780</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>JA</given-names></name><name><surname>Garon</surname><given-names>CF</given-names></name><name><surname>Schwan</surname><given-names>TG</given-names></name></person-group><article-title>Effects of environmental pH on membrane proteins of <italic>Borrelia burgdorferi</italic></article-title><source>Infect Immun.</source><year>1999</year><volume>67</volume><fpage>3181</fpage><lpage>3187</lpage><pub-id pub-id-type="pmid">10377088</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Freet</surname><given-names>KJ</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice</article-title><source>Infect Immun.</source><year>2003</year><volume>71</volume><fpage>5042</fpage><lpage>5055</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.9.5042-5055.2003</pub-id><pub-id pub-id-type="pmid">12933847</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>YP</given-names></name></person-group><article-title>Persister mechanisms in <italic>Borrelia burgdorferi</italic>: implications for improved intervention</article-title><source>EMI.</source><year>2015</year><volume>4</volume><fpage>e51</fpage><pub-id pub-id-type="pmid">26421273</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Guan</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name></person-group><article-title>RNA-Seq-based analysis of changes in <italic>Borrelia burgdorferi</italic> gene expression linked to pathogenicity</article-title><source>Parasites Vectors.</source><year>2015</year><volume>8</volume><fpage>155</fpage><pub-id pub-id-type="doi">10.1186/s13071-014-0623-2</pub-id><pub-id pub-id-type="pmid">25886272</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alban</surname><given-names>PS</given-names></name><name><surname>Johnson</surname><given-names>PW</given-names></name><name><surname>Nelson</surname><given-names>DR</given-names></name></person-group><article-title>Serum-starvation-induced changes in protein synthesis and morphology of <italic>Borrelia burgdorferi</italic></article-title><source>Microbiology.</source><year>2000</year><volume>146</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1099/00221287-146-1-119</pub-id><pub-id pub-id-type="pmid">10658658</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruntar</surname><given-names>I</given-names></name><name><surname>Malovrh</surname><given-names>T</given-names></name><name><surname>Murgia</surname><given-names>R</given-names></name><name><surname>Cinco</surname><given-names>M</given-names></name></person-group><article-title>Conversion of <italic>Borrelia garinii</italic> cystic forms to motile spirochetes <italic>in vivo</italic></article-title><source>APMIS.</source><year>2001</year><volume>109</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0463.2001.090507.x</pub-id><pub-id pub-id-type="pmid">11478686</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Persister cells</article-title><source>Annu Rev Microbiol.</source><year>2010</year><volume>64</volume><fpage>357</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.112408.134306</pub-id><pub-id pub-id-type="pmid">20528688</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Imai</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name></person-group><article-title>Resurgence of persisting non-cultivable <italic>Borrelia burgdorferi</italic> following antibiotic treatment in mice</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e86907</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0086907</pub-id><pub-id pub-id-type="pmid">24466286</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>AV</given-names></name><name><surname>Matluck</surname><given-names>NE</given-names></name><name><surname>Hu</surname><given-names>LT</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic>, the causative agent of Lyme disease, forms drug-tolerant persister cells</article-title><source>Antimicrob Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>4616</fpage><lpage>4624</lpage><pub-id pub-id-type="doi">10.1128/AAC.00864-15</pub-id><pub-id pub-id-type="pmid">26014929</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabello</surname><given-names>FC</given-names></name><name><surname>Godfrey</surname><given-names>HP</given-names></name><name><surname>Newman</surname><given-names>SA</given-names></name></person-group><article-title>Hidden in plain sight: <italic>Borrelia burgdorferi</italic> and the extracellular matrix</article-title><source>Trends Microbiol.</source><year>2007</year><volume>15</volume><fpage>350</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2007.06.003</pub-id><pub-id pub-id-type="pmid">17600717</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilly</surname><given-names>K</given-names></name><name><surname>Rosa</surname><given-names>PA</given-names></name><name><surname>Stewart</surname><given-names>PE</given-names></name></person-group><article-title>Biology of infection with <italic>Borrelia burgdorferi</italic></article-title><source>Infect Dis Clin N Am.</source><year>2007</year><volume>22</volume><fpage>217</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.idc.2007.12.013</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>FT</given-names></name><name><surname>Brown</surname><given-names>EL</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Iozzo</surname><given-names>RV</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name></person-group><article-title>Protective niche for <italic>Borrelia burgdorferi</italic> to evade humoral immunity</article-title><source>Am J Pathol.</source><year>2004</year><volume>165</volume><fpage>977</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63359-7</pub-id><pub-id pub-id-type="pmid">15331421</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yrj&#x000e4;n&#x000e4;inen</surname><given-names>H</given-names></name><name><surname>Hytonen</surname><given-names>J</given-names></name><name><surname>Soderstrom</surname><given-names>KO</given-names></name><name><surname>Oksi</surname><given-names>J</given-names></name><name><surname>Hartiala</surname><given-names>K</given-names></name><name><surname>Viljanen</surname><given-names>MK</given-names></name></person-group><article-title>Persistent joint swelling and <italic>Borrelia</italic>-specific antibodies in <italic>Borrelia garinii</italic>-infected mice after eradication of vegetative spirochetes with antibiotic treatment</article-title><source>Microbes Infect.</source><year>2006</year><volume>8</volume><fpage>2044</fpage><lpage>2051</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2006.03.008</pub-id><pub-id pub-id-type="pmid">16797205</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Holden</surname><given-names>K</given-names></name><name><surname>Freet</surname><given-names>KJ</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name></person-group><article-title>Persistence of <italic>Borrelia burgdorferi</italic> following antibiotic treatment in mice</article-title><source>Antimicrob Agents Chemother.</source><year>2008</year><volume>52</volume><fpage>1728</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.1128/AAC.01050-07</pub-id><pub-id pub-id-type="pmid">18316520</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>deSouza</surname><given-names>MS</given-names></name><name><surname>Janotka</surname><given-names>JL</given-names></name><name><surname>Smith</surname><given-names>AL</given-names></name><name><surname>Persing</surname><given-names>DH</given-names></name></person-group><article-title>Chronic Lyme borreliosis in the laboratory mouse</article-title><source>Am J Pathol.</source><year>1993</year><volume>143</volume><fpage>951</fpage><lpage>971</lpage></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Imai</surname><given-names>DM</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Luft</surname><given-names>BJ</given-names></name></person-group><article-title>Ineffectiveness of tigecycline against persistent <italic>Borrelia burgdorferi</italic></article-title><source>Antimicrob Agents Chemother.</source><year>2010</year><volume>54</volume><fpage>643</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1128/AAC.00788-09</pub-id><pub-id pub-id-type="pmid">19995919</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bockenstedt</surname><given-names>LK</given-names></name><name><surname>Gonzalez</surname><given-names>DG</given-names></name><name><surname>Haberman</surname><given-names>AM</given-names></name><name><surname>Belperron</surname><given-names>AA</given-names></name></person-group><article-title>Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy</article-title><source>J Clin Investig</source><year>2012</year><volume>122</volume><fpage>2652</fpage><lpage>2660</lpage><pub-id pub-id-type="doi">10.1172/JCI58813</pub-id><pub-id pub-id-type="pmid">22728937</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yrj&#x000e4;n&#x000e4;inen</surname><given-names>H</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>XR</given-names></name><name><surname>Oksi</surname><given-names>J</given-names></name><name><surname>Hartiala</surname><given-names>K</given-names></name><name><surname>Viljanen</surname><given-names>MK</given-names></name></person-group><article-title>Anti-tumor necrosis factor-&#x003b1; treatment activates <italic>Borrelia burgdorferi</italic> spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice</article-title><source>J Infect Dis.</source><year>2007</year><volume>195</volume><fpage>1489</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1086/513873</pub-id><pub-id pub-id-type="pmid">17436229</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yrj&#x000e4;n&#x000e4;inen</surname><given-names>H</given-names></name><name><surname>Hyt&#x000f6;nen</surname><given-names>J</given-names></name><name><surname>Hartiala</surname><given-names>P</given-names></name><name><surname>Oksi</surname><given-names>J</given-names></name><name><surname>Viljanen</surname><given-names>MK</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> DNA in joints and tissue adjacent to the joint is the niche of persisting burgdorferi in ceftriaxone-treated mice</article-title><source>APMIS.</source><year>2010</year><volume>118</volume><fpage>665</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0463.2010.02615.x</pub-id><pub-id pub-id-type="pmid">20718718</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>E</given-names></name><name><surname>Hue</surname><given-names>F</given-names></name><name><surname>Barbour</surname><given-names>AG</given-names></name></person-group><article-title>Experimental infections of the reservoir species <italic>Peromyscus leucopus</italic> with diverse strains of <italic>Borrelia burgdorferi</italic>, a Lyme disease agent</article-title><source>MBio.</source><year>2012</year><volume>3</volume><fpage>e00434-12</fpage><pub-id pub-id-type="doi">10.1128/mBio.00434-12</pub-id><pub-id pub-id-type="pmid">23221801</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwan</surname><given-names>TG</given-names></name><name><surname>Burgdorfer</surname><given-names>W</given-names></name><name><surname>Schrumpf</surname><given-names>ME</given-names></name><name><surname>Karstens</surname><given-names>RH</given-names></name></person-group><article-title>The urinary bladder: a consistent source of <italic>Borrelia burgdorferi</italic> in experimentally infected white-footed mice (<italic>Peromyscus leucopus</italic>)</article-title><source>J Clin Microbiol.</source><year>1988</year><volume>26</volume><fpage>893</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">3290239</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>KD</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>Terwilliger</surname><given-names>GA</given-names></name><name><surname>Beck</surname><given-names>DS</given-names></name><name><surname>Hansen</surname><given-names>GM</given-names></name><name><surname>Jacoby</surname><given-names>RO</given-names></name></person-group><article-title>Experimental chronic Lyme borreliosis in Lewis rats</article-title><source>Am J Trop Med Hyg.</source><year>1990</year><volume>42</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1990.42.165</pub-id><pub-id pub-id-type="pmid">2301706</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duray</surname><given-names>PH</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name></person-group><article-title>The histopathology of experimentally infected hamsters with the Lyme disease spirochete, <italic>Borrelia burgdorferi</italic></article-title><source>Proc Soc Exp Biol Med.</source><year>1986</year><volume>181</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.3181/00379727-181-42251</pub-id><pub-id pub-id-type="pmid">3945634</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>JL</given-names></name><name><surname>Jurkovich</surname><given-names>P</given-names></name><name><surname>Kodner</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name></person-group><article-title>Persistent cardiac and urinary tract infections with <italic>Borrelia burgdorferi</italic> in experimentally infected Syrian hamsters</article-title><source>J Clin Microbiol.</source><year>1991</year><volume>29</volume><fpage>894</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">2056054</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnesyn</surname><given-names>SW</given-names></name><name><surname>Manivel</surname><given-names>JC</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name><name><surname>Goodman</surname><given-names>JL</given-names></name></person-group><article-title>A guinea pig model for Lyme disease</article-title><source>Infect Immun.</source><year>1993</year><volume>61</volume><fpage>4777</fpage><lpage>4778</lpage><pub-id pub-id-type="pmid">8406878</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>JL</given-names></name><name><surname>Schell</surname><given-names>RF</given-names></name><name><surname>Lovrich</surname><given-names>SD</given-names></name><name><surname>Callister</surname><given-names>SM</given-names></name><name><surname>Coe</surname><given-names>JE</given-names></name></person-group><article-title>Characterization of the protective antibody response to <italic>Borrelia burgdorferi</italic> in experimentally infected LSH hamsters</article-title><source>Infect Immun.</source><year>1991</year><volume>59</volume><fpage>1916</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">2037352</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Patsouris</surname><given-names>E</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><name><surname>Gos</surname><given-names>B</given-names></name><name><surname>Mehraein</surname><given-names>P</given-names></name></person-group><article-title>Persistence of <italic>Borrelia burgdorferi</italic> and histopathological alterations in experimentally infected animals; comparison with histopathological findings in human Lyme disease</article-title><source>Infection.</source><year>1990</year><volume>18</volume><fpage>332</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1007/BF01646399</pub-id><pub-id pub-id-type="pmid">2076905</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straubinger</surname><given-names>RK</given-names></name><name><surname>Summers</surname><given-names>BA</given-names></name><name><surname>Chang</surname><given-names>YF</given-names></name><name><surname>Appel</surname><given-names>MJ</given-names></name></person-group><article-title>Persistence of <italic>Borrelia burgdorferi</italic> in experimentally infected dogs after antibiotic treatment</article-title><source>J Clin Microbiol.</source><year>1997</year><volume>35</volume><fpage>111</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">8968890</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straubinger</surname><given-names>RK</given-names></name><name><surname>Straubinger</surname><given-names>AF</given-names></name><name><surname>Summers</surname><given-names>BA</given-names></name><name><surname>Jacobson</surname><given-names>RH</given-names></name></person-group><article-title>Status of <italic>Borrelia burgdorferi</italic> infection after antibiotic treatment and the effects of corticosteroids: an experimental study</article-title><source>J Infect Dis.</source><year>2000</year><volume>181</volume><fpage>1069</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1086/315340</pub-id><pub-id pub-id-type="pmid">10720533</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straubinger</surname><given-names>RK</given-names></name><name><surname>Straubinger</surname><given-names>AF</given-names></name><name><surname>Jacobson</surname><given-names>RH</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Summers</surname><given-names>BA</given-names></name><name><surname>Erb</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Two lessons from the canine model of Lyme disease: migration of <italic>Borrelia burgdorferi</italic> in tissues and persistence after antibiotic treatment</article-title><source>J Spirochetal Tick Borne Dis.</source><year>1997</year><volume>4</volume><fpage>24</fpage><lpage>31</lpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YF</given-names></name><name><surname>Ku</surname><given-names>YW</given-names></name><name><surname>Chang</surname><given-names>CF</given-names></name><name><surname>Chang</surname><given-names>CD</given-names></name><name><surname>McDonough</surname><given-names>SP</given-names></name><name><surname>Divers</surname><given-names>T</given-names></name><etal/></person-group><article-title>Antibiotic treatment of experimentally <italic>Borrelia burgdorferi</italic>-infected ponies</article-title><source>Vet Microbiol.</source><year>2005</year><volume>107</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2005.02.006</pub-id><pub-id pub-id-type="pmid">15863289</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>DM</given-names></name><name><surname>Barr</surname><given-names>BC</given-names></name><name><surname>Daft</surname><given-names>B</given-names></name><name><surname>Bertone</surname><given-names>JJ</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><etal/></person-group><article-title>Lyme neuroborreliosis in 2 horses</article-title><source>Vet Pathol.</source><year>2011</year><volume>48</volume><fpage>1151</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1177/0300985811398246</pub-id><pub-id pub-id-type="pmid">21285382</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>FM</given-names></name><name><surname>Engiles</surname><given-names>JB</given-names></name><name><surname>Beech</surname><given-names>J</given-names></name></person-group><article-title>Meningitis, cranial neuritis, and radiculoneuritis associated with <italic>Borrelia burgdorferi</italic> infection in a horse</article-title><source>J Am Vet Med A.</source><year>2010</year><volume>10</volume><fpage>1180</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.2460/javma.237.10.1180</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Embers</surname><given-names>ME</given-names></name><name><surname>Hasenkampf</surname><given-names>NR</given-names></name><name><surname>Jacobs</surname><given-names>MB</given-names></name><name><surname>Tardo</surname><given-names>AC</given-names></name><name><surname>Doyle-Meyers</surname><given-names>LA</given-names></name><name><surname>Philipp</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to <italic>Borrelia burgdorferi</italic> by tick feeding</article-title><source>PLoS ONE.</source><year>2017</year><volume>12</volume><fpage>e0189071</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0189071</pub-id><pub-id pub-id-type="pmid">29236732</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>ED</given-names></name><name><surname>Bohm</surname><given-names>RP</given-names><suffix>Jr</suffix></name><name><surname>Cogswell</surname><given-names>FB</given-names></name><name><surname>Lanners</surname><given-names>HN</given-names></name><name><surname>Lowrie</surname><given-names>RC</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Chronic Lyme disease in the rhesus monkey</article-title><source>Lab Investig</source><year>1995</year><volume>72</volume><fpage>146</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">7853849</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>ED</given-names></name><name><surname>Bohm</surname><given-names>RP</given-names><suffix>Jr</suffix></name><name><surname>Lowrie</surname><given-names>RC</given-names><suffix>Jr</suffix></name><name><surname>Habicht</surname><given-names>G</given-names></name><name><surname>Katona</surname><given-names>L</given-names></name><name><surname>Piesman</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system</article-title><source>J Infect Dis.</source><year>1998</year><volume>178</volume><fpage>722</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1086/515357</pub-id><pub-id pub-id-type="pmid">9728541</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadavid</surname><given-names>D</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Narayan</surname><given-names>K</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>Pachner</surname><given-names>AR</given-names></name></person-group><article-title>Cardiac involvement in non-human primates infected with the Lyme disease spirochete <italic>Borrelia burgdorferi</italic></article-title><source>Lab Investig</source><year>2004</year><volume>84</volume><fpage>1439</fpage><lpage>1450</lpage><pub-id pub-id-type="doi">10.1038/labinvest.3700177</pub-id><pub-id pub-id-type="pmid">15448708</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hefty</surname><given-names>PS</given-names></name><name><surname>Brooks</surname><given-names>CS</given-names></name><name><surname>Jett</surname><given-names>AM</given-names></name><name><surname>White</surname><given-names>GL</given-names></name><name><surname>Wikel</surname><given-names>SK</given-names></name><name><surname>Kennedy</surname><given-names>RC</given-names></name><etal/></person-group><article-title>OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with <italic>Borrelia burgdorferi</italic> and in human Lyme disease patients</article-title><source>J Clin Microbiol.</source><year>2002</year><volume>40</volume><fpage>4256</fpage><lpage>4265</lpage><pub-id pub-id-type="doi">10.1128/JCM.40.11.4256-4265.2002</pub-id><pub-id pub-id-type="pmid">12409407</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stricker</surname><given-names>RB</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name></person-group><article-title>Persistent infection in chronic Lyme disease: does form matter?</article-title><source>Res J Infect Dis.</source><year>2013</year><volume>1</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.7243/2052-5958-1-2</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Embers</surname><given-names>ME</given-names></name><name><surname>Barthold</surname><given-names>SW</given-names></name><name><surname>Borda</surname><given-names>JT</given-names></name><name><surname>Bowers</surname><given-names>L</given-names></name><name><surname>Doyle</surname><given-names>L</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><etal/></person-group><article-title>Persistence of <italic>Borrelia burgdorferi</italic> in rhesus macaques following antibiotic treatment of disseminated infection</article-title><source>PLoS ONE.</source><year>2012</year><volume>7</volume><fpage>e29914</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0029914</pub-id><pub-id pub-id-type="pmid">22253822</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Malawista</surname><given-names>SE</given-names></name><name><surname>Hardin</surname><given-names>JA</given-names></name><name><surname>Ruddy</surname><given-names>S</given-names></name><name><surname>Askenase</surname><given-names>PW</given-names></name><name><surname>Andiman</surname><given-names>WA</given-names></name></person-group><article-title>Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum</article-title><source>Ann Intern Med.</source><year>1977</year><volume>86</volume><fpage>685</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-86-6-685</pub-id><pub-id pub-id-type="pmid">869348</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middelveen</surname><given-names>MJ</given-names></name><name><surname>Sapi</surname><given-names>E</given-names></name><name><surname>Burke</surname><given-names>J</given-names></name><name><surname>Filush</surname><given-names>KR</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Fesler</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Persistent borrelia infection in patients with ongoing symptoms of Lyme disease</article-title><source>Healthcare.</source><year>2018</year><volume>6</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.3390/healthcare6020033</pub-id><pub-id pub-id-type="pmid">29066168</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>BW</given-names></name></person-group><article-title>Treating erythema chronicum migrans of Lyme disease</article-title><source>J Am Acad Dermatol.</source><year>1986</year><volume>3</volume><fpage>459</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/S0190-9622(86)70194-1</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liegner</surname><given-names>KB</given-names></name><name><surname>Shapiro</surname><given-names>JR</given-names></name><name><surname>Ramsay</surname><given-names>D</given-names></name><name><surname>Halperin</surname><given-names>AJ</given-names></name><name><surname>Hogrefe</surname><given-names>W</given-names></name><name><surname>Kong</surname><given-names>L</given-names></name></person-group><article-title>Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting <italic>Borrelia burgdorferi</italic></article-title><source>J Am Acad Dermatol.</source><year>1993</year><volume>28</volume><fpage>312</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/0190-9622(93)70043-S</pub-id><pub-id pub-id-type="pmid">8436647</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidli</surname><given-names>J</given-names></name><name><surname>Hunziker</surname><given-names>T</given-names></name><name><surname>Moesli</surname><given-names>P</given-names></name><name><surname>Schaad</surname><given-names>UB</given-names></name></person-group><article-title>Cultivation of <italic>Borrelia burgdorferi</italic> from joint fluid three months after treatment of facial palsy due to Lyme borreliosis</article-title><source>J Inf Dis.</source><year>1988</year><volume>158</volume><fpage>905</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1093/infdis/158.4.905</pub-id><pub-id pub-id-type="pmid">3171237</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dattwyler</surname><given-names>RJ</given-names></name><name><surname>Volkman</surname><given-names>DJ</given-names></name><name><surname>Luft</surname><given-names>BJ</given-names></name><name><surname>Halperin</surname><given-names>JJ</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Golightly</surname><given-names>MG</given-names></name></person-group><article-title>Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte response to <italic>Borrelia burgdorferi</italic></article-title><source>N Engl J Med</source><year>1988</year><volume>319</volume><fpage>1441</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1056/NEJM198812013192203</pub-id><pub-id pub-id-type="pmid">3054554</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Bratzke</surname><given-names>HJ</given-names></name><name><surname>Neubert</surname><given-names>U</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Duray</surname><given-names>PH</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> in a newborn despite oral penicillin for Lyme borreliosis during pregnancy</article-title><source>Pediatr Infect Dis J.</source><year>1988</year><volume>7</volume><fpage>286</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1097/00006454-198804000-00010</pub-id><pub-id pub-id-type="pmid">3130607</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Duray</surname><given-names>PH</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name></person-group><article-title>Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue</article-title><source>Arthritis Rheum.</source><year>1988</year><volume>31</volume><fpage>487</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1002/art.1780310405</pub-id><pub-id pub-id-type="pmid">3258751</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Pfister</surname><given-names>HW</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Gross</surname><given-names>B</given-names></name><name><surname>Baumann</surname><given-names>A</given-names></name><etal/></person-group><article-title>Survival of <italic>Borrelia burgdorferi</italic> in antibiotically treated patients with Lyme borreliosis</article-title><source>Infection.</source><year>1989</year><volume>17</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1007/BF01645543</pub-id><pub-id pub-id-type="pmid">2613324</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girschick</surname><given-names>HJ</given-names></name><name><surname>Huppertz</surname><given-names>HI</given-names></name><name><surname>R&#x000fc;ssmann</surname><given-names>H</given-names></name><name><surname>Krenn</surname><given-names>V</given-names></name><name><surname>Karch</surname><given-names>H</given-names></name></person-group><article-title>Intracellular persistence of <italic>Borrelia burgdorferi</italic> in human synovial cells</article-title><source>Rheumatol Int.</source><year>1996</year><volume>16</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1007/BF01409985</pub-id><pub-id pub-id-type="pmid">8893378</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimmino</surname><given-names>MA</given-names></name><name><surname>Azzolini</surname><given-names>A</given-names></name><name><surname>Tobia</surname><given-names>F</given-names></name><name><surname>Pesce</surname><given-names>CM</given-names></name></person-group><article-title>Spirochetes in the spleen of a patient with chronic Lyme disease</article-title><source>Am J Clin Pathol.</source><year>1989</year><volume>91</volume><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1093/ajcp/91.1.95</pub-id><pub-id pub-id-type="pmid">2910019</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfister</surname><given-names>HW</given-names></name><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Schielke</surname><given-names>E</given-names></name><name><surname>Sorgel</surname><given-names>F</given-names></name><name><surname>Einhaupl</surname><given-names>KMJ</given-names></name></person-group><article-title>Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis</article-title><source>Infect Dis.</source><year>1991</year><volume>163</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1093/infdis/163.2.311</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logigian</surname><given-names>EL</given-names></name><name><surname>Kaplan</surname><given-names>RF</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name></person-group><article-title>Chronic neurologic manifestations of Lyme disease</article-title><source>N Engl J Med.</source><year>1990</year><volume>323</volume><fpage>1438</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1056/NEJM199011223232102</pub-id><pub-id pub-id-type="pmid">2172819</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battafarano</surname><given-names>DF</given-names></name><name><surname>Combs</surname><given-names>JA</given-names></name><name><surname>Enzenauer</surname><given-names>RJ</given-names></name><name><surname>Fitzpatrick</surname><given-names>JE</given-names></name></person-group><article-title>Chronic septic arthritis caused by <italic>Borrelia burgdorferi</italic></article-title><source>Clin Orthop.</source><year>1993</year><volume>297</volume><fpage>238</fpage><lpage>241</lpage></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;upl</surname><given-names>T</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name><name><surname>Rittig</surname><given-names>M</given-names></name><name><surname>Krause</surname><given-names>A</given-names></name><name><surname>Schoerner</surname><given-names>C</given-names></name><name><surname>Schonherr</surname><given-names>U</given-names></name><etal/></person-group><article-title>Persistence of <italic>Borrelia burgdorferi</italic> in ligamentous tissue from a patient with chronic Lyme borreliosis</article-title><source>Arthritis Rheum.</source><year>1993</year><volume>36</volume><fpage>1621</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1002/art.1780361118</pub-id><pub-id pub-id-type="pmid">8240439</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strle</surname><given-names>F</given-names></name><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Cimperman</surname><given-names>J</given-names></name><name><surname>Ruzic</surname><given-names>E</given-names></name><name><surname>Maraspin</surname><given-names>V</given-names></name><name><surname>Jereb</surname><given-names>M</given-names></name></person-group><article-title>Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings</article-title><source>Infection.</source><year>1993</year><volume>21</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1007/BF01710737</pub-id><pub-id pub-id-type="pmid">8387966</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Pfister</surname><given-names>HW</given-names></name><name><surname>Spiegel</surname><given-names>H</given-names></name><name><surname>Burk</surname><given-names>R</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><etal/></person-group><article-title>First isolation of <italic>Borrelia burgdorferi</italic> from an iris biopsy</article-title><source>J Clin Neuroophthalmol.</source><year>1993</year><volume>13</volume><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">8106639</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strle</surname><given-names>F</given-names></name><name><surname>Maraspin</surname><given-names>V</given-names></name><name><surname>Lotric-Furlan</surname><given-names>S</given-names></name><name><surname>Ruzi&#x000e7;-Sablji&#x000e7;</surname><given-names>E</given-names></name><name><surname>Cimperman</surname><given-names>J</given-names></name></person-group><article-title>Azithromycin and doxycycline for treatment of <italic>Borrelia</italic> culture-positive erythema migrans</article-title><source>Infection.</source><year>1996</year><volume>24</volume><fpage>64</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1007/BF01780661</pub-id><pub-id pub-id-type="pmid">8852473</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preac-Mursic</surname><given-names>V</given-names></name><name><surname>Marget</surname><given-names>W</given-names></name><name><surname>Busch</surname><given-names>U</given-names></name><name><surname>Pleterski Rigler</surname><given-names>D</given-names></name><name><surname>Hagl</surname><given-names>S</given-names></name></person-group><article-title>Kill kinetics of <italic>Borrelia burgdorferi</italic> and bacterial findings in relation to the treatment of Lyme borreliosis</article-title><source>Infection.</source><year>1996</year><volume>24</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/BF01780643</pub-id><pub-id pub-id-type="pmid">8852456</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shadick</surname><given-names>NA</given-names></name><name><surname>Phillips</surname><given-names>CB</given-names></name><name><surname>Logigian</surname><given-names>EL</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Kaplan</surname><given-names>RF</given-names></name><name><surname>Berardi</surname><given-names>VP</given-names></name><etal/></person-group><article-title>The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study</article-title><source>Ann Int Med.</source><year>1994</year><volume>121</volume><fpage>560</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-121-8-199410150-00002</pub-id><pub-id pub-id-type="pmid">8085687</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksi</surname><given-names>J</given-names></name><name><surname>Kalimo</surname><given-names>H</given-names></name><name><surname>Marttila</surname><given-names>RJ</given-names></name><name><surname>Marjam&#x000e4;ki</surname><given-names>M</given-names></name><name><surname>Sonninen</surname><given-names>P</given-names></name><name><surname>Nikoskelainen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature</article-title><source>Brain.</source><year>1996</year><volume>119</volume><fpage>2143</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.1093/brain/119.6.2143</pub-id><pub-id pub-id-type="pmid">9010017</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priem</surname><given-names>S</given-names></name><name><surname>Burmester</surname><given-names>GR</given-names></name><name><surname>Kamradt</surname><given-names>T</given-names></name><name><surname>Wolbart</surname><given-names>K</given-names></name><name><surname>Rittig</surname><given-names>MG</given-names></name><name><surname>Krause</surname><given-names>A</given-names></name></person-group><article-title>Detection of <italic>Borrelia burgdorferi</italic> by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy</article-title><source>Ann Rheum Dis.</source><year>1998</year><volume>57</volume><fpage>118</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1136/ard.57.2.118</pub-id><pub-id pub-id-type="pmid">9613343</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksi</surname><given-names>J</given-names></name><name><surname>Marjamaki</surname><given-names>M</given-names></name><name><surname>Nikoskelainen</surname><given-names>J</given-names></name><name><surname>Viljanen</surname><given-names>MK</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis</article-title><source>Ann Med.</source><year>1999</year><volume>31</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.3109/07853899909115982</pub-id><pub-id pub-id-type="pmid">10442678</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>K</given-names></name></person-group><article-title>Treatment failure in erythema migrans: a review</article-title><source>Infection.</source><year>1996</year><volume>24</volume><fpage>73</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/BF01780663</pub-id><pub-id pub-id-type="pmid">8852475</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honegr</surname><given-names>K</given-names></name><name><surname>Hul&#x000ed;nsk&#x000e1;</surname><given-names>D</given-names></name><name><surname>Beran</surname><given-names>J</given-names></name><name><surname>Dost&#x000e1;l</surname><given-names>V</given-names></name><name><surname>Havlasov&#x000e1;</surname><given-names>J</given-names></name><name><surname>&#x0010c;erm&#x000e1;kov&#x000e1;</surname><given-names>Z</given-names></name></person-group><article-title>Long term and repeated electron microscopy and PCR detection of <italic>Borrelia burgdorferi sensu lato</italic> after an antibiotic treatment</article-title><source>Cent Eur J Public Health.</source><year>2004</year><volume>12</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15068199</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breier</surname><given-names>F</given-names></name><name><surname>Khanakah</surname><given-names>G</given-names></name><name><surname>Stanek</surname><given-names>G</given-names></name><name><surname>Kunz</surname><given-names>G</given-names></name><name><surname>Aberer</surname><given-names>E</given-names></name><name><surname>Schmidt</surname><given-names>B</given-names></name><etal/></person-group><article-title>Isolation and polymerase chain reaction typing of <italic>Borrelia afzelii</italic> from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus</article-title><source>Br J Dermatol.</source><year>2001</year><volume>144</volume><fpage>387</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2133.2001.04034.x</pub-id><pub-id pub-id-type="pmid">11251580</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunfeld</surname><given-names>KP</given-names></name><name><surname>Ruzic-Sabljic</surname><given-names>E</given-names></name><name><surname>Norris</surname><given-names>DE</given-names></name><name><surname>Kraiczy</surname><given-names>P</given-names></name><name><surname>Strle</surname><given-names>F</given-names></name></person-group><article-title><italic>In vitro</italic> susceptibility testing of <italic>Borrelia burgdorferi sensu lato</italic> isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy</article-title><source>Antimicrob Agents Chemother.</source><year>2005</year><volume>49</volume><fpage>1294</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.4.1294-1301.2005</pub-id><pub-id pub-id-type="pmid">15793100</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>BJ</given-names></name><name><surname>Stewart</surname><given-names>M</given-names></name><name><surname>Lennox</surname><given-names>VA</given-names></name><name><surname>Fukunaga</surname><given-names>M</given-names></name><name><surname>Yabuki</surname><given-names>M</given-names></name><name><surname>Macorison</surname><given-names>H</given-names></name><etal/></person-group><article-title>Culture-positive Lyme borreliosis</article-title><source>Med J Aust.</source><year>1998</year><volume>168</volume><fpage>500</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.5694/j.1326-5377.1998.tb141415.x</pub-id><pub-id pub-id-type="pmid">9631675</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsch</surname><given-names>M</given-names></name><name><surname>Ruben</surname><given-names>FL</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Duray</surname><given-names>PH</given-names></name><name><surname>Norden</surname><given-names>CW</given-names></name><name><surname>Winkelstein</surname><given-names>A</given-names></name></person-group><article-title>Fatal adult respiratory distress syndrome in a patient with Lyme disease</article-title><source>J Am Med Assoc.</source><year>1988</year><volume>259</volume><fpage>2737</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1001/jama.1988.03720180063034</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chancellor</surname><given-names>MB</given-names></name><name><surname>McGinnis</surname><given-names>DE</given-names></name><name><surname>Shenot</surname><given-names>PJ</given-names></name><name><surname>Kiilholma</surname><given-names>P</given-names></name><name><surname>Hirsch</surname><given-names>IH</given-names></name></person-group><article-title>Urinary dysfunction in Lyme disease</article-title><source>J Urol.</source><year>1993</year><volume>149</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(17)35989-X</pub-id><pub-id pub-id-type="pmid">8417211</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nocton</surname><given-names>JJ</given-names></name><name><surname>Dressler</surname><given-names>F</given-names></name><name><surname>Rutledge</surname><given-names>BJ</given-names></name><name><surname>Rys</surname><given-names>PN</given-names></name><name><surname>Persing</surname><given-names>DH</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name></person-group><article-title>Detection of <italic>Borrelia burgdorferi</italic> DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis</article-title><source>N Engl J Med.</source><year>1994</year><volume>330</volume><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1056/NEJM199401273300401</pub-id><pub-id pub-id-type="pmid">8272083</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masters</surname><given-names>E</given-names></name></person-group><article-title>Spirochetemia after continuous high-dose oral amoxicillin therapy</article-title><source>Infect Dis Clin Pract</source><year>1994</year><volume>3</volume><fpage>207</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1097/00019048-199405000-00016</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>C</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Lowy</surname><given-names>FD</given-names></name><name><surname>Coyle</surname><given-names>PK</given-names></name></person-group><article-title>Seronegative chronic relapsing neuroborreliosis</article-title><source>Eur Neurol.</source><year>1995</year><volume>35</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1159/000117104</pub-id><pub-id pub-id-type="pmid">7796837</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>ME</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bayer</surname><given-names>MH</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases</article-title><source>Infection</source><year>1996</year><volume>24</volume><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1007/BF01716077</pub-id><pub-id pub-id-type="pmid">8923044</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nocton</surname><given-names>JJ</given-names></name><name><surname>Bloom</surname><given-names>BJ</given-names></name><name><surname>Rutledge</surname><given-names>BJ</given-names></name></person-group><article-title>Detection of <italic>Borrelia burgdorferi</italic> DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis</article-title><source>J Infect Dis.</source><year>1996</year><volume>174</volume><fpage>623</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1093/infdis/174.3.623</pub-id><pub-id pub-id-type="pmid">8769624</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudenko</surname><given-names>N</given-names></name><name><surname>Golovchenko</surname><given-names>M</given-names></name><name><surname>Vancova</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Grubhoffer</surname><given-names>L</given-names></name><name><surname>Oliver</surname><given-names>JH</given-names><suffix>Jr</suffix></name></person-group><article-title>Isolation of live <italic>Borrelia burgdorferi sensu lato</italic> spirochetes from patients with undefined disorders and symptoms not typical for Lyme diseases</article-title><source>Clin Microbiol Infect.</source><year>2016</year><volume>22</volume><fpage>267.e9</fpage><lpage>267.e15</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2015.11.009</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>ED</given-names></name></person-group><article-title>Repeat or persistent Lyme disease: persistence, recrudescence or reinfection with <italic>Borrelia burgdorferi</italic>?</article-title><source>F1000Prime Rep.</source><year>2015</year><volume>7</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.12703/P7-11</pub-id><pub-id pub-id-type="pmid">25705394</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Embers</surname><given-names>ME</given-names></name><name><surname>Ramamoorthy</surname><given-names>R</given-names></name><name><surname>Philipp</surname><given-names>MT</given-names></name></person-group><article-title>Survival strategies of <italic>Borrelia burgdorferi</italic>, the etiologic agent of Lyme disease</article-title><source>Microb Infect.</source><year>2004</year><volume>6</volume><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2003.11.014</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steere</surname><given-names>AC</given-names></name></person-group><article-title>Lyme disease</article-title><source>N Engl J Med.</source><year>2001</year><volume>345</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1056/NEJM200107123450207</pub-id><pub-id pub-id-type="pmid">11450660</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wormser</surname><given-names>GP</given-names></name><name><surname>Dattwyler</surname><given-names>RJ</given-names></name><name><surname>Shapiro</surname><given-names>ED</given-names></name><name><surname>Halperin</surname><given-names>JJ</given-names></name><name><surname>Steere</surname><given-names>AC</given-names></name><name><surname>Klempner</surname><given-names>MS</given-names></name><etal/></person-group><article-title>The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis.</source><year>2006</year><volume>43</volume><fpage>1089</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1086/508667</pub-id><pub-id pub-id-type="pmid">17029130</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>LT</given-names></name></person-group><article-title>In the clinic. Lyme disease</article-title><source>Ann Intern Med.</source><year>2012</year><volume>157</volume><fpage>ITC2-2</fpage><lpage>ITC2-16</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-157-3-201208070-01002</pub-id><pub-id pub-id-type="pmid">22868858</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobby</surname><given-names>GL</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Chaffee</surname><given-names>E</given-names></name></person-group><article-title>Observations on the mechanism of action of penicillin</article-title><source>Exp Biol Med.</source><year>1942</year><volume>50</volume><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.3181/00379727-50-13773</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigger</surname><given-names>JW</given-names></name></person-group><article-title>Treatment of staphylococcal infections with penicillin by intermittent sterilization</article-title><source>Lancet.</source><year>1944</year><volume>244</volume><fpage>497</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)74210-3</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname><given-names>I</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Spoering</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Persister cells and tolerance to antimicrobials</article-title><source>FEMS Microbiol Lett.</source><year>2004</year><volume>230</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/S0378-1097(03)00856-5</pub-id><pub-id pub-id-type="pmid">14734160</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauvart</surname><given-names>M</given-names></name><name><surname>De Groote</surname><given-names>VN</given-names></name><name><surname>Michiels</surname><given-names>J</given-names></name></person-group><article-title>Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies</article-title><source>J Med Microbiol.</source><year>2011</year><volume>60</volume><fpage>699</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.030932-0</pub-id><pub-id pub-id-type="pmid">21459912</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Persisters, persistent infections and the Yin-Yang model</article-title><source>Emerg Microbes Infect.</source><year>2014</year><volume>3</volume><fpage>e3</fpage><pub-id pub-id-type="pmid">26038493</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapi</surname><given-names>E</given-names></name><name><surname>Bastian</surname><given-names>SL</given-names></name><name><surname>Mpoy</surname><given-names>CM</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Rattelle</surname><given-names>A</given-names></name><name><surname>Pabbati</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization of biofilm formation by <italic>Borrelia burgdorferi in vitro</italic></article-title><source>PLoS ONE.</source><year>2012</year><volume>7</volume><fpage>e48277</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0048277</pub-id><pub-id pub-id-type="pmid">23110225</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtti</surname><given-names>TJ</given-names></name><name><surname>Munderloh</surname><given-names>UG</given-names></name><name><surname>Johnson</surname><given-names>RC</given-names></name><name><surname>Ahlstrand</surname><given-names>GG</given-names></name></person-group><article-title>Colony formation and morphology in <italic>Borrelia burgdorferi</italic></article-title><source>J Clin Microbiol.</source><year>1987</year><volume>25</volume><fpage>2054</fpage><lpage>2058</lpage><pub-id pub-id-type="pmid">3693538</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aberer</surname><given-names>E</given-names></name><name><surname>Kersten</surname><given-names>A</given-names></name><name><surname>Klade</surname><given-names>H</given-names></name><name><surname>Poitschek</surname><given-names>C</given-names></name><name><surname>Jurecka</surname><given-names>W</given-names></name></person-group><article-title>Heterogeneity of <italic>Borrelia burgdorferi</italic> in the skin</article-title><source>Am J Dermatopathol.</source><year>1996</year><volume>18</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1097/00000372-199612000-00004</pub-id><pub-id pub-id-type="pmid">8989928</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mursic</surname><given-names>VP</given-names></name><name><surname>Wanner</surname><given-names>G</given-names></name><name><surname>Reinhardt</surname><given-names>S</given-names></name><name><surname>Wilske</surname><given-names>B</given-names></name><name><surname>Busch</surname><given-names>U</given-names></name><name><surname>Marget</surname><given-names>W</given-names></name></person-group><article-title>Formation and cultivation of <italic>Borrelia burgdorferi</italic> spheroplast-L-form variants</article-title><source>Infection.</source><year>1996</year><volume>24</volume><fpage>218</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1007/BF01781096</pub-id><pub-id pub-id-type="pmid">8811359</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brorson</surname><given-names>O</given-names></name><name><surname>Brorson</surname><given-names>SH</given-names></name></person-group><article-title>Transformation of cystic forms of <italic>Borrelia burgdorferi</italic> to normal, mobile spirochetes</article-title><source>Infection.</source><year>1997</year><volume>25</volume><fpage>240</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1007/BF01713153</pub-id><pub-id pub-id-type="pmid">9266264</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miklossy</surname><given-names>J</given-names></name><name><surname>Kasas</surname><given-names>S</given-names></name><name><surname>Zurn</surname><given-names>AD</given-names></name><name><surname>McCall</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>McGeer</surname><given-names>PL</given-names></name></person-group><article-title>Persisting atypical and cystic forms of <italic>Borrelia burgdorferi</italic> and local inflammation in Lyme borreliosis</article-title><source>J Neuroinflamm</source><year>2008</year><volume>5</volume><fpage>40</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-5-40</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapi</surname><given-names>E</given-names></name><name><surname>Kaur</surname><given-names>N</given-names></name><name><surname>Anyanwu</surname><given-names>S</given-names></name><name><surname>Luecke</surname><given-names>DF</given-names></name><name><surname>Datar</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><etal/></person-group><article-title>Evaluation of <italic>in-vitro</italic> antibiotic susceptibility of different morphological forms of <italic>Borrelia burgdorferi</italic></article-title><source>Infect Drug Resist.</source><year>2011</year><volume>4</volume><fpage>97</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">21753890</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meril&#x000e4;inen</surname><given-names>L</given-names></name><name><surname>Herranen</surname><given-names>A</given-names></name><name><surname>Schwarzbach</surname><given-names>A</given-names></name><name><surname>Gilbert</surname><given-names>L</given-names></name></person-group><article-title>Morphological and biochemical features of <italic>Borrelia burgdorferi</italic> pleomorphic form</article-title><source>Microbiology.</source><year>2015</year><volume>161</volume><fpage>516</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000027</pub-id><pub-id pub-id-type="pmid">25564498</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murgia</surname><given-names>R</given-names></name><name><surname>Cinco</surname><given-names>M</given-names></name></person-group><article-title>Induction of cystic forms by different stress conditions in <italic>Borrelia burgdorferi</italic></article-title><source>APMIS.</source><year>2004</year><volume>112</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0463.2004.apm1120110.x</pub-id><pub-id pub-id-type="pmid">14961976</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kersten</surname><given-names>A</given-names></name><name><surname>Poitschek</surname><given-names>C</given-names></name><name><surname>Rauch</surname><given-names>S</given-names></name><name><surname>Aberer</surname><given-names>E</given-names></name></person-group><article-title>Effects of penicillin, ceftriaxone, and doxycycline on morphology of <italic>Borrelia burgdorferi</italic></article-title><source>Antimicrob Agents Chemother.</source><year>1995</year><volume>39</volume><fpage>1127</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1128/AAC.39.5.1127</pub-id><pub-id pub-id-type="pmid">7625800</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brorson</surname><given-names>O</given-names></name><name><surname>Brorson</surname><given-names>SH</given-names></name><name><surname>Scythes</surname><given-names>J</given-names></name><name><surname>MacAllister</surname><given-names>J</given-names></name><name><surname>Wier</surname><given-names>A</given-names></name><name><surname>Margulis</surname><given-names>L</given-names></name></person-group><article-title>Destruction of spirochete <italic>Borrelia burgdorferi</italic> round-body propagules (RBs) by the antibiotic tigecycline</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>18656</fpage><lpage>18661</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908236106</pub-id><pub-id pub-id-type="pmid">19843691</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caskey</surname><given-names>JR</given-names></name><name><surname>Embers</surname><given-names>ME</given-names></name></person-group><article-title>Persister development by <italic>Borrelia burgdorferi</italic> populations <italic>in vitro</italic></article-title><source>Antimicrob Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>6288</fpage><lpage>6295</lpage><pub-id pub-id-type="doi">10.1128/AAC.00883-15</pub-id><pub-id pub-id-type="pmid">26248368</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Sullivan</surname><given-names>D</given-names></name><name><surname>Auwaerter</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Identification of novel activity against <italic>Borrelia burgdorferi</italic> persisters using an FDA approved drug library</article-title><source>EMI.</source><year>2014</year><volume>3</volume><fpage>e49</fpage><pub-id pub-id-type="pmid">26038747</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Sullivan</surname><given-names>D</given-names></name><name><surname>Auwaerter</surname><given-names>PG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>A drug combination screen identifies drugs active against amoxicillin-induced round bodies of <italic>in vitro Borrelia burgdorferi</italic> persisters from an FDA drug library</article-title><source>Front Microbiol.</source><year>2016</year><volume>7</volume><fpage>743</fpage><pub-id pub-id-type="pmid">27242757</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubinina</surname><given-names>G</given-names></name><name><surname>Grabovich</surname><given-names>M</given-names></name><name><surname>Leshcheva</surname><given-names>N</given-names></name><name><surname>Rainey</surname><given-names>FA</given-names></name><name><surname>Gavrish</surname><given-names>E</given-names></name></person-group><article-title><italic>Spirochaeta perfilievii</italic> sp. nov., a novel oxygen-tolerant, sulfide oxidizing, sulfur and thiosulfate reducing spirochete isolated from a saline spring</article-title><source>Int J Syst Evol Microbiol</source><year>2011</year><volume>61</volume><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1099/ijs.0.018333-0</pub-id><pub-id pub-id-type="pmid">20173011</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droge</surname><given-names>S</given-names></name><name><surname>Frohlich</surname><given-names>J</given-names></name><name><surname>Radek</surname><given-names>R</given-names></name><name><surname>Konig</surname><given-names>H</given-names></name></person-group><article-title><italic>Spirochaeta coccoides</italic> sp. nov., a novel coccoid spirochete from the hindgut of the termite <italic>Neotermes castaneus</italic></article-title><source>Appl Environ Microbiol.</source><year>2006</year><volume>72</volume><fpage>391</fpage><lpage>397</lpage></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutton</surname><given-names>JE</given-names></name><name><surname>Todd</surname><given-names>JL</given-names></name></person-group><article-title>The nature of human tick fever in the eastern part of the Congo Free State</article-title><source>Liverpool Sch Trop Med Hyg.</source><year>1905</year><volume>17</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogenraad</surname><given-names>NJ</given-names></name><name><surname>Hird</surname><given-names>FJR</given-names></name><name><surname>Holmes</surname><given-names>I</given-names></name><name><surname>Millis</surname><given-names>NF</given-names></name></person-group><article-title>Bacteriophages in rumen contents of sheep</article-title><source>J Gen Virol.</source><year>1967</year><volume>1</volume><fpage>575</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-1-4-575</pub-id><pub-id pub-id-type="pmid">6081706</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapi</surname><given-names>E</given-names></name><name><surname>Balasubramanian</surname><given-names>K</given-names></name><name><surname>Poruri</surname><given-names>A</given-names></name><name><surname>Maghsoudlou</surname><given-names>JS</given-names></name><name><surname>Theophilus</surname><given-names>PAS</given-names></name><name><surname>Socarras</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Evidence of <italic>in vivo</italic> existence of <italic>Borrelia</italic> biofilm in borrelial lymphocytomas</article-title><source>Eur J Microbiol Immunol.</source><year>2016</year><volume>6</volume><fpage>9</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1556/1886.2015.00049</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisendle</surname><given-names>K</given-names></name><name><surname>Zelger</surname><given-names>B</given-names></name></person-group><article-title>The expanding spectrum of cutaneous borreliosis</article-title><source>G Ital Dermatol Venereol.</source><year>2009</year><volume>144</volume><fpage>157</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">19357623</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivares</surname><given-names>J</given-names></name><name><surname>Bernardini</surname><given-names>A</given-names></name><name><surname>Garcia-Leon</surname><given-names>G</given-names></name><name><surname>Corona</surname><given-names>FB</given-names></name><name><surname>Sanchez</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>JL</given-names></name></person-group><article-title>The intrinsic resistome of bacterial pathogens</article-title><source>Front Microbiol.</source><year>2013</year><volume>4</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2013.00103</pub-id><pub-id pub-id-type="pmid">23641241</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Auwaerter</surname><given-names>PG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Drug combinations against <italic>Borrelia burgdorferi</italic> persisters <italic>in vitro</italic>: eradication achieved by using daptomycin, cefoperazone and doxycycline</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0117207</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0117207</pub-id><pub-id pub-id-type="pmid">25806811</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefferson</surname><given-names>KK</given-names></name></person-group><article-title>What drives bacteria to produce biofilm?</article-title><source>FEMS Microbiol Lett.</source><year>2004</year><volume>236</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2004.tb09643.x</pub-id><pub-id pub-id-type="pmid">15251193</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donlan</surname><given-names>RM</given-names></name><name><surname>Costerton</surname><given-names>JW</given-names></name></person-group><article-title>Biofilms: survival mechanisms of clinically relevant microorganisms</article-title><source>Clin Microbiol Rev.</source><year>2002</year><volume>15</volume><fpage>167</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1128/CMR.15.2.167-193.2002</pub-id><pub-id pub-id-type="pmid">11932229</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><article-title>Riddle of biofilm resistance</article-title><source>Antimicrob Agents Chemother.</source><year>2001</year><volume>45</volume><fpage>999</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1128/AAC.45.4.999-1007.2001</pub-id><pub-id pub-id-type="pmid">11257008</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Toole</surname><given-names>G</given-names></name><name><surname>Kaplan</surname><given-names>HB</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><article-title>Biofilm formation as microbial development</article-title><source>Annu Rev Microbiol.</source><year>2000</year><volume>54</volume><fpage>49</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.54.1.49</pub-id><pub-id pub-id-type="pmid">11018124</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name><name><surname>Geesey</surname><given-names>GG</given-names></name><name><surname>Cheng</surname><given-names>KJ</given-names></name></person-group><article-title>How bacteria stick</article-title><source>Sci Am.</source><year>1978</year><volume>238</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1038/scientificamerican0178-86</pub-id><pub-id pub-id-type="pmid">635520</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesey</surname><given-names>PM</given-names></name><name><surname>Kuramitsu</surname><given-names>HK</given-names></name></person-group><article-title>Genetic analysis of <italic>Treponema denticola</italic> ATCC 35405 biofilm formation</article-title><source>Microbiol.</source><year>2004</year><volume>150</volume><fpage>2401</fpage><lpage>2407</lpage><pub-id pub-id-type="doi">10.1099/mic.0.26816-0</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ristow</surname><given-names>P</given-names></name><name><surname>Bourhy</surname><given-names>P</given-names></name><name><surname>Kerneis</surname><given-names>S</given-names></name><name><surname>Schmitt</surname><given-names>C</given-names></name><name><surname>Prevost</surname><given-names>M-C</given-names></name><name><surname>Lilenbaum</surname><given-names>W</given-names></name><etal/></person-group><article-title>Biofilm formation by saprophytic and pathogenic leptospires</article-title><source>Microbiol.</source><year>2008</year><volume>154</volume><fpage>1309</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2007/014746-0</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name><name><surname>Lewandowski</surname><given-names>Z</given-names></name><name><surname>Caldwell</surname><given-names>DE</given-names></name><name><surname>Korber</surname><given-names>DR</given-names></name><name><surname>Lappin-Scott</surname><given-names>HM</given-names></name></person-group><article-title>Microbial biofilms</article-title><source>Annu Rev Microbiol.</source><year>1995</year><volume>49</volume><fpage>711</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.49.100195.003431</pub-id><pub-id pub-id-type="pmid">8561477</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Speert</surname><given-names>DP</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Tu</surname><given-names>J</given-names></name><name><surname>Witt</surname><given-names>M</given-names></name><name><surname>Nast</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of <italic>Pseudomonas aeruginosa</italic></article-title><source>Infect Immun.</source><year>1991</year><volume>59</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">1898898</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gacesa</surname><given-names>P</given-names></name></person-group><article-title>Bacterial alginate biosynthesis: recent progress and future prospects</article-title><source>Microbiology.</source><year>1998</year><volume>144</volume><fpage>1133</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1099/00221287-144-5-1133</pub-id><pub-id pub-id-type="pmid">9611788</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname><given-names>T-FC</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>GA</given-names></name></person-group><article-title>Mechanisms of biofilm resistance to antimicrobial agents</article-title><source>Trends Microbiol.</source><year>2001</year><volume>1</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/S0966-842X(00)01913-2</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>JW</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name><name><surname>Greenburg</surname><given-names>EP</given-names></name></person-group><article-title>Bacterial biofilms, a common cause of persistent infections</article-title><source>Science.</source><year>1999</year><volume>284</volume><fpage>1318</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1126/science.284.5418.1318</pub-id><pub-id pub-id-type="pmid">10334980</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branda</surname><given-names>SS</given-names></name><name><surname>Vik</surname><given-names>S</given-names></name><name><surname>Friedman</surname><given-names>L</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><article-title>Biofilms: the matrix revisited</article-title><source>Trends Microbiol.</source><year>2005</year><volume>13</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2004.11.006</pub-id><pub-id pub-id-type="pmid">15639628</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remminghorst</surname><given-names>U</given-names></name><name><surname>Rehm</surname><given-names>BHA</given-names></name></person-group><article-title>Bacterial alginates: from biosynthesis to applications</article-title><source>Biotechnol Lett.</source><year>2006</year><volume>28</volume><fpage>1701</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.1007/s10529-006-9156-x</pub-id><pub-id pub-id-type="pmid">16912921</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmierczak</surname><given-names>MJ</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>Boor</surname><given-names>KJ</given-names></name></person-group><article-title>Alternative sigma factors and their roles in bacterial virulence</article-title><source>Microbiol Mol Biol Rev.</source><year>2005</year><volume>69</volume><fpage>527</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1128/MMBR.69.4.527-543.2005</pub-id><pub-id pub-id-type="pmid">16339734</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>Z</given-names></name><name><surname>Narasimhan</surname><given-names>S</given-names></name><name><surname>Neelakanta</surname><given-names>G</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Pal</surname><given-names>U</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name><etal/></person-group><article-title>Activation of the RpoN&#x02013;RpoS regulatory pathway during the enzootic life cycle of <italic>Borrelia burgdorferi</italic></article-title><source>BMC Microbiol.</source><year>2012</year><volume>12</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-12-44</pub-id><pub-id pub-id-type="pmid">22443136</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham-Ems</surname><given-names>SM</given-names></name><name><surname>Caimano</surname><given-names>MJ</given-names></name><name><surname>Eggers</surname><given-names>CH</given-names></name><name><surname>Radolf</surname><given-names>JD</given-names></name></person-group><article-title><italic>Borrelia burgdorferi</italic> requires the alternative sigma factor RpoS for dissemination within the vector during tick-to mammal transmission</article-title><source>PLoS Pathog.</source><year>2012</year><volume>8</volume><fpage>e1002532</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002532</pub-id><pub-id pub-id-type="pmid">22359504</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>CM</given-names></name><name><surname>Bassler</surname><given-names>BL</given-names></name></person-group><article-title>Quorum sensing: cell-to-cell communication in bacteria</article-title><source>Annu Rev Cell Dev Biol.</source><year>2005</year><volume>21</volume><fpage>319</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.21.012704.131001</pub-id><pub-id pub-id-type="pmid">16212498</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassler</surname><given-names>BL</given-names></name></person-group><article-title>How bacteria talk to each other: regulation of gene expression by quorum sensing</article-title><source>Curr Opin Microbiol.</source><year>1999</year><volume>2</volume><fpage>582</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/S1369-5274(99)00025-9</pub-id><pub-id pub-id-type="pmid">10607620</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schauder</surname><given-names>S</given-names></name><name><surname>Shokat</surname><given-names>K</given-names></name><name><surname>Surette</surname><given-names>MG</given-names></name><name><surname>Bassler</surname><given-names>BL</given-names></name></person-group><article-title>The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule</article-title><source>Mol Microbiol.</source><year>2001</year><volume>41</volume><fpage>463</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02532.x</pub-id><pub-id pub-id-type="pmid">11489131</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theophilus</surname><given-names>PA</given-names></name><name><surname>Victoria</surname><given-names>MJ</given-names></name><name><surname>Socarras</surname><given-names>KM</given-names></name><name><surname>Filush</surname><given-names>KR</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Luecke</surname><given-names>DF</given-names></name><etal/></person-group><article-title>Effectiveness of <italic>Stevia rebaudiana</italic> whole leaf extract against the various morphological forms of <italic>Borrelia burgdorferi in vitro</italic></article-title><source>Eur J Microbiol Immunol.</source><year>2015</year><volume>5</volume><fpage>268</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1556/1886.2015.00031</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Zubcevik</surname><given-names>N</given-names></name><name><surname>Miklossy</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Selective essential oils from spice or culinary herbs have high activity against stationary phase and biofilm <italic>Borrelia burgdorferi</italic></article-title><source>Front Med</source><year>2017</year><volume>4</volume><fpage>169</fpage><pub-id pub-id-type="doi">10.3389/fmed.2017.00169</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Miklossy</surname><given-names>J</given-names></name><name><surname>Tauxe</surname><given-names>GM</given-names></name><name><surname>McMeniman</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Identification of essential oils with strong activity against stationary phase <italic>Borrelia burgdorferi</italic></article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><fpage>89</fpage><pub-id pub-id-type="doi">10.3390/antibiotics7040089</pub-id></element-citation></ref></ref-list></back></article>